Related references
Note: Only part of the references are listed.Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI
M. Ewers et al.
NEUROLOGY (2007)
CSF A beta 42, Tau and phosphorylated Tau, APOE epsilon 4 allele and MCI type in progressive MCI
Sanna-Kaisa Herukka et al.
NEUROBIOLOGY OF AGING (2007)
Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment
Zhenyu Zhong et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger et al.
BRAIN (2006)
Are the CSF levels of 24S-hydroxychole sterol a sensitive biomarker for mild cognitive impairment?
V Leoni et al.
NEUROSCIENCE LETTERS (2006)
Apolipoprotein (apo) E4 enhances amyloid β peptide production in cultured neuronal cells:: ApoE structure as a potential therapeutic target
SM Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Neurovascular mechanisms of Alzheimer's neurodegeneration
BV Zlokovic
TRENDS IN NEUROSCIENCES (2005)
Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease
DK Lahiri et al.
NEUROBIOLOGY OF AGING (2004)
Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients
R Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease
TL Bailey et al.
NEUROLOGICAL RESEARCH (2004)
The effect of oxidative stress on amyloid precursor protein processing in cells engaged in β-amyloidosis is related to apolipoprotein E genotype
B Mazur-Kolecka et al.
ACTA NEUROPATHOLOGICA (2004)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Alzheimer's disease: the cholesterol connection
L Puglielli et al.
NATURE NEUROSCIENCE (2003)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
LB Yang et al.
NATURE MEDICINE (2003)
24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia
A Papassotiropoulos et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2002)
Current concepts in mild cognitive impairment
RC Petersen et al.
ARCHIVES OF NEUROLOGY (2001)
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
K Fassbender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10
E Kojro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma
H Vanderstichele et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2000)
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
DM Holtzman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
